| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9762 | 
      | Human Intestinal Absorption | HIA+ | 1.0000 | 
      | Caco-2 Permeability | Caco2+ | 0.7733 | 
      | P-glycoprotein Substrate | Substrate | 0.7066 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.7716 | 
                                                     | Non-inhibitor | 0.7160 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7901 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8483 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8251 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9117 | 
      | CYP450 3A4 Substrate | Substrate | 0.7701 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9425 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9506 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.6103 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9304 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9526 | 
                                                                    | Non-inhibitor | 0.7342 | 
      | AMES Toxicity | Non AMES toxic | 0.9345 | 
      | Carcinogens | Non-carcinogens | 0.9474 | 
      | Fish Toxicity | High FHMT | 0.9924 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9834 | 
      | Honey Bee Toxicity | High HBT | 0.8245 | 
      | Biodegradation | Not ready biodegradable | 0.9754 | 
      | Acute Oral Toxicity | IV | 0.5200 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5040 |